Company iSpecimen Inc.

ISPC

US45032V3069

Software

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-07 EDT			5-day change	1st Jan Change
2.220 ^USD	+0.91%		+21.31%	-78.66%

08-07	ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants	MT
05-18	ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Business description: iSpecimen Inc.

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Companyâ€™s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

Number of employees: 7

Sales by Activity: iSpecimen Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Pharmacy Services	11.14M	10.4M	9.93M	9.29M	1.93M

See all business segments

Geographical breakdown of sales: iSpecimen Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Americas	10.32M	9.31M	8.93M	7.91M	1.83M
Europe, Middle East, and Africa (EMEA)	745K	773K	903K	1.18M	55.56K
Asia Pacific (APAC)	67.92K	289K	96.3K	201K	45.91K

See all geographic segments

Executive Committee: iSpecimen Inc.

Manager	Title	Age	Since
Katharyn Field CEO	Chief Executive Officer	32	2025-11-06
Yu Ying Liang DFI	Director of Finance/CFO	36	2024-12-12
Leslie Hoyt COO	Chief Operating Officer	-	-
Annette Arnold SAM	Sales & Marketing	-	2022-11-30
Carly Lejnieks SAM	Sales & Marketing	-	2018-12-31

See ISPECIMEN INC. governance

Composition of the Board of Directors: iSpecimen Inc.

Director	Title	Age	Since
Avtar Dhaliwal BRD	Director/Board Member	31	2024-09-24
Anthony Lau BRD	Director/Board Member	41	2025-06-19
Arphing Lee BRD	Director/Board Member	35	2025-11-06

Composition of the Board of Directors

Shareholders: iSpecimen Inc.

Name	Stocks	%	Valuation
IFP Advisors LLC 0.5706 %	8,200	0.5706 %	21 730 $
Geode Capital Management LLC 0.5446 %	7,827	0.5446 %	20 742 $
Jane Street Group LLC 0.0968 %	1,391	0.0968 %	3 686 $
UBS Group AG (13f Subfiler) 0.0935 %	1,344	0.0935 %	3 562 $
Citadel Securities GP LLC 0.0878 %	1,262	0.0878 %	3 344 $

List of ISPECIMEN INC. shareholders

Company details: iSpecimen Inc.

iSpecimen, Inc.

8 Cabot Road

01801, Woburn

http://www.ispecimen.com

Other Software

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ISPECIMEN INC.	+0.91%	+21.31%	-96.72%	-99.79%	3.16M
MICROSOFT CORPORATION	+0.03%	+10.84%	-4.75%	+52.54%	3,712B
PALANTIR TECHNOLOGIES INC.	+10.32%	+40.69%	-4.19%	+845.11%	375B
CADENCE DESIGN SYSTEMS, INC.	+0.24%	+1.93%	-5.81%	+48.14%	93.2B
DATADOG, INC.	+2.02%	-12.89%	+70.80%	+117.55%	81.62B
SYNOPSYS, INC.	+2.47%	+11.73%	-33.54%	-5.76%	77.74B
SEA LIMITED	+2.19%	+6.77%	-23.12%	+90.83%	67.99B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+6.04%	-0.38%	+8.49%	+73.37%	43.47B
DASSAULT SYSTÈMES SE	+2.39%	+10.09%	-19.15%	-41.11%	33.15B
ZOOM COMMUNICATIONS, INC.	+3.16%	+13.19%	+42.82%	+51.32%	29.7B
Average	+0.22%	+6.82%	-6.52%	+113.22%	451.33B
Weighted average by Cap.	-0.07%	+11.19%	-3.80%	+118.50%